Eli Lilly Operating Income 2010-2024 | LLY

Eli Lilly operating income for the twelve months ending September 30, 2024 was $10.424B, a 17.37% increase year-over-year.

  • Eli Lilly annual operating income for 2023 was $6.458B, a 9.39% decline from 2022.
  • Eli Lilly annual operating income for 2022 was $7.127B, a 12.12% increase from 2021.
  • Eli Lilly annual operating income for 2021 was $6.357B, a 4.94% increase from 2020.

Eli Lilly Operating Income 2010-2024 | LLY

  • Eli Lilly annual operating income for 2023 was $6.458B, a 9.39% decline from 2022.
  • Eli Lilly annual operating income for 2022 was $7.127B, a 12.12% increase from 2021.
  • Eli Lilly annual operating income for 2021 was $6.357B, a 4.94% increase from 2020.
Related Stocks
Company NameMarket
Cap
Novo Nordisk (NVO)$460.6B
Johnson & Johnson (JNJ)$368.4B
AbbVie (ABBV)$294.4B
Merck (MRK)$244.2B
Novartis AG (NVS)$211.1B
AstraZeneca (AZN)$197.8B
Pfizer (PFE)$142.2B
Sanofi (SNY)$121.8B
Innoviva (INVA)$1.2B